Request Demo
Last update 22 Mar 2025
LX-22001
Last update 22 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms LX22001 |
Target |
Action- |
Mechanism P-CAB(Potassium-competitive acid blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with LX-22001NCT06561542
A Phase I, Escalating Single and Multiple Dose Study of LX22001 for Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Bioavailability in Healthy Subjects.
CTR20242538
注射用LX22001在健康成年受试者中单次/多次给药后的安全性、耐受性、药代动力学和药效学特征及生物利用度的I期临床研究
[Translation] Phase I clinical study on the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics and bioavailability of LX22001 for injection in healthy adult subjects after single/multiple administration
CTR20250723
一项评价注射用LX22001对比注射用艾司奥美拉唑钠用于消化性溃疡出血经内镜治疗后降低再出血风险的疗效和安全性的多中心、随机、双盲、双模拟的Ⅱ 期临床试验
[Translation] A multicenter, randomized, double-blind, double-dummy Phase II clinical trial to evaluate the efficacy and safety of LX22001 for injection versus esomeprazole sodium for injection in reducing the risk of rebleeding after endoscopic treatment of peptic ulcer bleeding
100 Clinical Results associated with LX-22001
Login to view more data
100 Translational Medicine associated with LX-22001
Login to view more data
100 Patents (Medical) associated with LX-22001
Login to view more data
100 Deals associated with LX-22001
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peptic Ulcer Hemorrhage | Phase 2 | China | 19 Mar 2025 | |
| Duodenal Ulcer | Phase 1 | China | 31 Jul 2024 | |
| Esophagitis, Peptic | Phase 1 | China | 31 Jul 2024 | |
| Hemorrhage | IND Approval | China | 11 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free